Page 1

Hepatitis B Virus Market

What is Hepatitis B Virus? Hepatitis is the inflammation of the liver. The condition can be limited to self or can advance to scarring, cirrhosis or liver cancer. Hepatitis viruses are the most common origin of hepatitis in all over the world. Sometimes, other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis. One of the viruses is the Hepatitis B Virus (HBV) that causes Hepatitis B, which is a life-threatening liver infection. It is a significant concern and a significant global health problem. It can be an acute infection or a chronic infection. Chronic Hepatitis B Virus infection is the main cause of chronic hepatitis and advanced-stage liver diseases, including cirrhosis and hepatocellular carcinoma (HCC). Hepatitis B virus (HBV) is a blood-borne and sexually-transmitted virus, which is acquired by percutaneous and mucosal exposure to blood or/ and body fluids of an infected person. The clinical manifestations of hepatitis from different origins may be quite similar.


Hepatitis B Virus Epidemiology Hepatitis B Virus (HBV) Infection is estimated to have 786,000 deaths and the vast majority being attributable to liver cancer (341,000 deaths) and cirrhosis (312,000 deaths). Hepatitis B Virus (HBV) infection ranks 15th among all causes of human mortality.

Hepatitis B Virus Market Now taking into consideration of Hepatitis market, it is dominated by chronic Hepatitis B medication, which focuses on viral suppression and includes two therapy classes, oral nucleoside analogues (NUC) – Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) and pegylated interferon (PEG-IFN). For acute hepatitis B infection, no specific treatment is available; only care is focused on maintaining comfort and required nutritional balance, including replacement of fluids (lost due to vomiting), etc. Many companies are developing therapies for global hepatitis dugs market. DelveInsight is one such company that prepares market reports, pipeline reports, and epidemiology reports. It proffers a detailed overview of the Hepatitis B market size and an in-depth comprehension of the historical and forecasted Hepatitis B market epidemiology. It shows Hepatitis B therapeutic market treatment patterns, potential upcoming hepatitis drugs market and also recognises the best of the hepatitis b drug market forecast opportunities by showing the current and forecasted Hepatitis B market revenue, sales trends, and drug uptake during the study period from 2017-2028. The Hepatitis B market report also proffers in-depth analysis of the disease overview by including details like disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The exhaustive details about hepatitis b treatment market algorithms and treatment guidelines in the United States, Europe, and Japan are also provided in the report.

Profile for Kritika Rehani

Hepatitis B Virus Market  

Hepatitis is the inflammation of the liver. The condition can be limited to self or can advance to scarring, cirrhosis or liver cancer. Hepa...

Hepatitis B Virus Market  

Hepatitis is the inflammation of the liver. The condition can be limited to self or can advance to scarring, cirrhosis or liver cancer. Hepa...